Case 1 Shahinda wahba 5033 Dina bawahab 5090 Wid nahas 5069 Doaa bayumi 5580 Ayat al-hindy Latifa abdulrahman.

Slides:



Advertisements
Similar presentations
Chapter 19 Hematologic Products.
Advertisements

Evidence-Based Management of Anticoagulant Therapy
Drugs for Coagulation Disorders
BREAST RECONSTRUCTION FORUM
Warfarin toxicity Presented by: Dr.Somaia Janah Presented by: Dr.Somaia Janah.
STROKESTROKESTROKESTROKE. Why Change? Improve Mortality Improve Mortality Devastating and Life Altering Devastating and Life Altering Cost expense of.
Warfarin Sodium (Anticoagulant) Therapy Training 03/10/2015.
O.C.P. Introduction to Endodontics Alan H. Gluskin DDS Professor and Chair Department of Endodontics.
Post oral surgery bleeding for adult patients receiving antithrombotic therapy.
Medications that impact bleeding By Nino Lalaiants Inesa Legrian NYCCT 2012.
Best Practices in Meeting NPSG 3E-Anticoagulation Requirements MaryAnne Cronin, PharmD Assistant Director of Pharmacy Glen Cove Hospital.
ANAESTHESIA AND ANTICOAGULANTS
Regional Anesthetics and Anticoagulation Marie Sankaran Raval M.D. Boston Medical Center Department of Anesthesiology Nina Zachariah M.D.
Anticoagulation In Dental Procedures Galila Zaher MRCPath KAU Assistant Professor.
Anticoagulation in the Acute Care Population Aimee Ring PT, DPT, GCS.
Surgery with a Prosthetic Valve- What about the Warfarin? COPYRIGHT © 2014, ALL RIGHTS RESERVED From the Publishers of.
What You Need to Know about Blood Clots. What You Need to Know About Blood Clots or Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE)
WARFARIN AN OVERVIEW.
Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications Mark Bleackley MEDG 505 March.
Peri-operative management of anticoagulation Marc Carrier MD, MSc FRCPC Assistant Professor, University of Ottawa Associate Scientist, Ottawa Health Research.
Study Guide Guide for Patients Undergoing Anticoagulant Therapy.
Ten years follow up of hereditary hemorrhagic patients in the dental practice Makris SP, Makris MP, Makris PE Haemostasis and Thrombosis Unit, Aristotle.
Understanding Heart Disease In this lesson, you will Learn About… Different types of heart disease. How heart disease is treated. What you can do to reduce.
Anticoagulation Transitions: Perioperative Care Alan Brush, MD, FACP Clinical Co-Director, Anticoagulation Management Service Harvard Vanguard Medical.
Anticoagulants By: Darrel Dejvongsa. About Anticoagulants Anticoagulants also called Blood Thinners help prevent existing blood clots form becoming larger.
Oral Rivaroxaban for Symptomatic Venous Thrombroenbolism Group /06/11.
  The prothrombin time is therefore the time required for the plasma to clot after an excess of thromboplastin and an optimal concentration of calcium.
Developed by: Dawn Johnson, RN, MSN, Ed.  Internally and externally  Prevent bleeding from wounds which could lead to shock or even death.
Pulmonary Embolism Pulmonary embolism is blockage in one or more arteries in your lungs. Maggie Trainor.
Anticoagulations and Coagulants
Derek Landreth and Chase Patrylak. Cerebrovascular Accident (Stroke) A stroke is when a clogged or burst artery interrupts blood flow to the brain. A.
MEDICAL HISTORY. WHY TAKE A MEDICAL HISTORY? Individuals are surviving what used to be fatal diseases and have more chronic conditions Dental treatment.
Peri-Operative anticoagulation /antiplatelet therapy A Shift in Paradigm BMHGT04/29/09.
 Deep Vein Thrombosis Josh Vrona, Hunter Dolan, Erin McCann.
Drugs Susan Louw Haematology Registrar. 4 Questions to ask: Can I stop? (What is the risk of thrombosis?) Should I stop? (What is the risk of bleeding?)
COMMON LIFESTYLE DISEASES: STROKE EMS 355 By: Dr. Bushra Bilal.
General principles for preventing high INR Simple dental or dermatological procedures may not require interruption to warfarin therapy. Simple dental.
Agents Affecting Blood Clotting
Coagulation Modifier Agents Lilley Pharmacology Text: Chapter 26 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed. Professor of Nursing Original.
Chapter 19 Agents affecting Blood Clotting. Blood Clotting p461 Clotting is necessary to prevent fatal loss of blood from a minor injury Thromboemboli.
DVT cases.  Heparin, low molecular weight heparin, or fondaparinux are usually continued for at least five days, along with another medication called.
Antithrombotic and Thrombolytic Therapy for Valvular Disease Copyright: American College of Chest Physicians 2012 © Antithrombotic Therapy and Prevention.
One of the main causes of DVT is inactivity! When a person is inactive, your blood normally collects in the lower part of your body. (in your legs) This.
Anticoagulant Therapy
Antithrombotic and Thrombolytic Therapy for Valvular Disease Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest.
Case Presentation Done by: Lara Abbar Hadeel Al-Shareef Sarah Ghassal Raghad Bajaber Alia Al-Sayed Raghdah Mandili.
Principles of prevention of infection Yaser Baroud.
Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation NEJM Aug 27, 2015.
Introduction - Perioperative management of patients on warfarin or antiplatelet therapy involves assessing and balancing individual risks for thromboembolism.
Cardiac Emergency/Disorders
Bleeding disorders Deficiency of any of the clotting factors leads to excessive bleeding Most common and important bleeding disorders are due Vitamin K.
Heart Condition Presentation
Evidence-Based Management of Anticoagulant Therapy
Management of Patients on Chronic Oral Anticoagulant Therapy
Understanding Atrial Fibrillation and Stroke Risk
By: Dr. Nalaka Gunawansa
Dr.H.Chandrashekar, Dr.A.Chaudhuri, Dr. A. Douglas, Dr. D. Lowdon
what is carotid angioplasty?
The normal haemostasis process involves three stages: 1
Prevention of Venous Thromboembolism in Orthopedic Surgery Patients
Prepare for the Tooth Extraction in an Effective Way
Anticoagulation Prepared by Cherie Gan.
ANTICOAGULANTS Dr. A. Shyam Sundar. M.Pharm., Ph.D,
Effective interprofessional communication is vital when planning surgical procedures for medically complicated individuals on anticoagulants. Thromboembolism.
Prevention and Management of Venous Thromboembolic Events in Patients With Multiple Myeloma.
Pharmacogenomics Genes and Drugs.
Deep Vein Thrombosis By Jonah Paul Cox.
Thrombophilia in pregnancy: Whom to screen, when to treat
(p for noninferiority = 0.01)
Prevention and Management of Venous Thromboembolic Events in Patients With Multiple Myeloma.
Presentation transcript:

Case 1 Shahinda wahba 5033 Dina bawahab 5090 Wid nahas 5069 Doaa bayumi 5580 Ayat al-hindy Latifa abdulrahman

Introduction: Anticoagulants are medicines that help prevent blood clots. They're given to people at a high risk of getting clots, to reduce their chances of developing serious conditions such as strokes and heart attacks.

A blood clot is a seal created by the blood to stop bleeding from wounds. While they're useful in stopping bleeding, they can block blood vessels and stop blood flowing to organs such as the brain, heart or lungs if they form in the wrong place.blood clot Anticoagulants work by interrupting the process involved in the formation of blood clots. They're sometimes called "blood-thinning" medicines, although they don't actually make the blood thinner. Although they're used for similar purposes, anticoagulants are different to antiplatelet medicines,

Types of anticoagulants The most commonly prescribed anticoagulant is warfarin.warfarin Warfarin and the newer alternatives are taken as tablets or capsules. There's also an anticoagulant called heparin that can be given by injection.heparin

Warfarin also known by the brand names Coumadin among others, is an anticoagulant normally used in the prevention of thrombosis and thromboembolism, the formation of blood clots in the blood vessels and their migration elsewhere in the body, respectively. anticoagulant normally used in the prevention of thrombosis and thromboembolism, the formation of blood clots in the blood vessels and their migration elsewhere in the body, respectively

How does Warfarin Work Warfarin acts by inhibiting the synthesis of vitamin K-dependent clotting factors, which include Factors II, VII, IX, and X, and the anticoagulant proteins C and S.anticoagulant proteins C and S.

Heparins Heparin is an injectable anticoagulant that is used to prevent the formation of blood clots in the vessels. It is a highly-sulfated glycosaminoglycan. Heparin works by decreasing the clotting ability of the blood, helping to prevent the formation of clots as well as stopping the further expansion of any existing clots. it is also used to manage and treat blood clots that may occur in the heart, legs and lungs.

How does Heparin Work Heparin works by decreasing the clotting ability of the blood, helping to prevent the formation of clots as well as stopping the further expansion of any existing clots. it is also used to manage and treat blood clots that may occur in the heart, legs and lungs.

Evaluate safety of dental treatment for patients with Warfarin (Coumadin) : A. Procedures involved low risk of bleeding: Examination, Radiographs, Study Models Safety profile based on INR: INR < : Safe to proceed in a routine manner. INR >3.5: Can be safely performed with judicious use of local hemostatic measures in many instances

B. Procedures involved low-moderate risk of bleeding: Examples Simple restorative dentistry Supragingival prophylaxis Complex restorative dentistry Scaling and root planning Endodontics Safety profile based on INR: INR <1.5-3: Safe to proceed in a routine manner. INR >3: Not advised to do procedures. Need to refer to physician for adjustment of warfarin therapy.

C. Procedures involved moderate risk of bleeding: Examples: Simple extraction up to 3 teeth Curettage Gingivoplasty Removal of single bony impaction Crown and bridge procedure Safety profile based on INR: INR < : Can be safe to proceed with judicious use of local hemostatic measures in some instances. INR > 3.5: Not advised to do procedures. Need to refer to physician for adjustment of warfarin therapy.

D. Procedures involved moderate-high risk of bleeding: Examples: Gingivectomy Apicoectomy Minor periodontal flap surgery Placement of single implant Safety profile based on INR: Not sufficient scientific data to draw a conclusion for any INR values. Not advised to do procedures. Need to refer to physician for adjustment of warfarin therapy and evaluate all factors for risk assessment.

E.Procedures involved high risk of bleeding: Examples: Full-mouth/Full-arch extractions Extensive flap surgery Extraction of multiple bony impactions Multiple implant placement Safety profile based on INR: Not sufficient scientific data to draw a conclusion for any INR values. Not advised to do procedures. Need to refer to physician for adjustment of warfarin therapy and evaluate all factors for risk assessment. Local hemostatic measures included: Gelatin sponges with silk sutures Systemic, irrigant, and mouthrinse forms of tranexamic acid Vasoconstrictors in local anesthetic Atraumatic surgical techniques

Three options for alteration of warfarin (coumadin ) status: Option 1: After consult with physician → 2-3 day cessation of warfarin therapy → determine INR: If INR is unacceptable, defer an additional day → repeat INR → perform dental treatment only when INR is in an acceptable range → resume warfarin therapy on the evening of the same day of dental procedure. If INR is acceptable → perform dental treatment → resume warfarin therapy on the evening of the same day of dental procedure.

Option 2: After consult with physician with an unacceptable INR: Discontinue warfarin therapy several days before surgery (or other dental treatment) and substitute heparin anticoagulant therapy or Low molecular weight heparin (LMWH). Heparin then can be discontinue 6-8 hours before surgery or Low molecular weight can be discontinued the day before surgery. Warfarin or heparin or LMWH can be readministered shortly (12-18 hours) after surgery.

Option 3: (Not Recommended) After consult with physician, stop warfarin therapy for 4-5 days before performing dental treatment. Warfarin is then resumed after the dental treatment. Not recommended because ↑ risk of thrombotic complications due to underlying disease.